Matinas BioPharma
MTNB
MTNB
45 hedge funds and large institutions have $18M invested in Matinas BioPharma in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.
Holders
45
Holders Change
+26
Holders Change %
+136.84%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
5
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$4.14M |
| 2 |
2
BlackRock
New York
|
$4.05M |
| 3 |
IA
3
IFP Advisors
Tampa,
Florida
|
$1.18M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$1.13M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$980K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BCM
51
BlueCrest Capital Management
St Helier,
Jersey
| – | – | -24,000 | Closed |
|
52
Barclays
London,
United Kingdom
| $0 | 41 | +41 | New |
|